Trials / Completed
CompletedNCT05142215
A Placebo-controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention for the Relief of Stable Angina
ORBITA-CTO Pilot: A Comparison of the Impact of CTO PCI Versus Placebo on Angina in Patients With Background Optimal Medical Therapy - a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Mid and South Essex NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ORBITA-CTO Pilot is a double blinded randomised placebo-controlled trial comparing the effects of chronic total occlusion percutaneous coronary intervention versus placebo on symptoms of angina in patients with background optimal medical therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous coronary intervention | Percutaneous coronary intervention using drug eluting stents and contemporary CTO PCI techniques on background of optimal medical therapy. |
| PROCEDURE | Placebo percutaneous coronary intervention | Placebo percutaneous coronary intervention procedure on background of optimal medical therapy. |
Timeline
- Start date
- 2021-10-19
- Primary completion
- 2025-10-21
- Completion
- 2025-10-21
- First posted
- 2021-12-02
- Last updated
- 2025-11-20
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05142215. Inclusion in this directory is not an endorsement.